Viekira XR is a co-formulation of four active ingredients — dasabuvir, ombitasvir, paritaprevir and ritonavir — that are present in Abbvie’s Viekira Pak, which is already on the market.
Viekira XR, taken once daily as three oral tablets, represents the first treatment available for adults with chronic genotype 1 hepatitis C virus that combines three direct-acting antivirals.
North Chicago, Ill.-based AbbVie did not specify when Viekira XR will hit the market.
More articles about the drug market:
‘Pain refugees’ travel out of Montana for access to opioid prescriptions
Sen. Bernie Sanders’ DNC speech tackles high prescription drug costs: 4 things to know
Eli Lily exceeds 2Q expectations thanks to new drug sales
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
